Leveraging the power of the Recursion OS, we are building an industry-leading pipeline of potential best-in-class and first-in-class therapeutic assets. We focus on indications with high unmet need, …

All of our results feed back into our drug discovery and drug development platform – the Recursion Operating System – in a continuously improving feedback loop.

Aug 8, 2024 · Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montreal, the San …

Oct 9, 2025 · Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, …

The Investor Relations website contains information about Recursion Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.

Jun 30, 2025 · Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, …

Dave Hallett comes to Recursion after approximately 5 years as the Chief Scientific Officer and Interim CEO of Exscientia. David Hallett, Ph.D., is an experienced “drug hunter” with over 20 years’ track …

ir.recursion.com

Dive into an interactive experience with our pipeline, partners and models.

Mar 31, 2025 · In total, the partnership has generated $130 million of cash inflows (including an upfront payment) to Recursion to date. Recursion’s collaboration within Neuroscience and a GI Oncology …